Liz Garrett-Mayer

66PUBLICATIONS
308CO-AUTHORS
Molecular targetsMultimorbidityPacific Peoples biomedical and clinical scienceCancer therapy (excl. chemotherapy and radiation therapy)Medical genetics (excl. cancer genetics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Jul 15, 2026
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Apr 30, 2026
Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Apr 30, 2026
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Apr 22, 2026
Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

|Jan 15, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Daniel R Carrizosa, Michael Rothe, Pam K Mangat

|Oct 16, 2025
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Tareq Al Baghdadi, Michael Rothe, Pam K Mangat

Pageof 11

Frequent Collaborators

23 joint publications

Richard L Schilsky

23 joint publications

Susan Halabi

22 joint publications

Pam Mangat

20 joint publications

Gina N Grantham